MEF2D, myocyte enhancer factor 2D, 4209

N. diseases: 72; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1332986
Disease: Childhood Osteosarcoma
Childhood Osteosarcoma
0.030 AlteredExpression disease BEFREE EPIC1 was down-regulated, but MEF2D was up-regulated in OS tissues and OS cell lines. 30703420 2019
CUI: C1332986
Disease: Childhood Osteosarcoma
Childhood Osteosarcoma
0.030 Biomarker disease BEFREE Overall, our study demonstrated that miR-30a functions as a tumor suppressor by targeting MEF2D in osteosarcoma, providing a promising prognostic biomarker and a therapeutic strategy for osteosarcoma. 29713188 2018
CUI: C1332986
Disease: Childhood Osteosarcoma
Childhood Osteosarcoma
0.030 Biomarker disease BEFREE Collectively, our results demonstrated that MEF2D is a candidate oncogene for osteosarcoma and a potential molecular target for cancer therapy. 25814384 2015